BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) EBIT

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) (BIOSU) currently reports a EBIT of $-1.1M as of June 2023. That compares with $-560K in the prior-year period — down 89.5% year over year. That is above the sector sector average of $-63M. Use the charts on this page to explore BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s EBIT history and peer comparisons.

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s EBIT decreased from $-560K to $-1.1M — a 89.5% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s EBIT of $-1.1M is higher than the its sector sector average of $-63M. That is roughly 98.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) reported $-1.1M in EBIT as of June 2023. That compares with $-560K in the prior-year period — down 89.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-63M. From there, open related valuation or income-statement pages for BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War), and consider following BIOSU for alerts when major investors trade the stock.